Valion Bio Inc (VBIO)

05:23 AM

[PRE 14A] Valion Bio, Inc. Preliminary Proxy Statement - Stock Titan

05:23 AM

05:16 AM

Form PRE 14A Valion Bio Inc For: 7 July By Investing.com - Investing.com Canada

05:16 AM

Jul 06, 2026

VBIOValion Bio Inc Dividends - Finviz

Jul 06, 2026

Jul 04, 2026

Price to book forward of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Jul 04, 2026

Jul 01, 2026

Enterprise value to EBIT forward of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Jul 01, 2026

Jul 01, 2026

Price to earnings forward of Valion Bio, Inc. – NASDAQ:VBIO - TradingView

Jul 01, 2026

Jun 27, 2026

Valion Bio (VBIO) Stock Analysis Report | Financials & Insights - Benzinga

Jun 27, 2026

Jun 25, 2026

Valion Bio’s Entolimod gets protocol design for radiation syndrome study - Investing.com

Jun 25, 2026

Jun 25, 2026

Valion Bio, Inc. Actuals & Estimates (NASDAQ:VBIO) - TradingView

Jun 25, 2026

Jun 25, 2026

AFRRI/NIAID finishes Entolimod test plan for GI radiation illness - Stock Titan

Jun 25, 2026

Jun 18, 2026

Valion Bio (VBIO) CFO exercises 92 RSUs, holds 618 common shares after conversion - Stock Titan

Jun 18, 2026

Jun 18, 2026

Valion Bio Completes New Preferred Stock Financing Round - TipRanks

Jun 18, 2026

Jun 18, 2026

Valion Bio issues preferred shares and warrants in $250,000 private placement By Investing.com - Investing.com South Africa

Jun 18, 2026

Jun 18, 2026

Valion Bio issues preferred shares and warrants in $250,000 private placement - Investing.com UK

Jun 18, 2026

Jun 18, 2026

Valion Bio (NASDAQ: VBIO) adds $250,000 via Series B preferred share and warrant sale - Stock Titan

Jun 18, 2026

Jun 12, 2026

VBIO Price Today: Valion Bio, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Jun 12, 2026

Jun 11, 2026

Valion Bio's Initiative for Radiation Protection Solutions - GuruFocus

Jun 11, 2026

Jun 11, 2026

House committee directs Pentagon plan for radiation drugs By Investing.com - Investing.com Australia

Jun 11, 2026

Jun 11, 2026

House committee directs Pentagon plan for radiation drugs - Investing.com UK

Jun 11, 2026

Jun 11, 2026

Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Com - GuruFocus

Jun 11, 2026

Jun 11, 2026

Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures - PR Newswire

Jun 11, 2026

Jun 11, 2026

Congress presses for radiation drugs that work before and after exposure - Stock Titan

Jun 11, 2026

Jun 03, 2026

Valion Bio (NASDAQ: VBIO) investors approve major equity plan boost and share issuances - Stock Titan

Jun 03, 2026

May 28, 2026

VBIO News | VALION BIO INC (NASDAQ:VBIO) - ChartMill

May 28, 2026

May 27, 2026

VBIO Stock Price, Quote & Chart | VALION BIO INC (NASDAQ:VBIO) - ChartMill

May 27, 2026

May 20, 2026

VBIO SEC FilingsValion Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 20, 2026

May 20, 2026

Valion Bio (VBIO) CEO converts 2,206 RSUs, now holds 11,030 shares - Stock Titan

May 20, 2026

May 19, 2026

Quest Diagnostics Declares Quarterly Cash Dividend - Weekly Voice

May 19, 2026

May 19, 2026

Valion radiation drug, oral option in joint US defense, BARDA briefing - Stock Titan

May 19, 2026

May 19, 2026

VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME - Yahoo Finance

May 19, 2026

May 17, 2026

Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work - MSN

May 17, 2026

May 15, 2026

Valion Bio subsidiary secures exclusive NMR platform license By Investing.com - Investing.com Australia

May 15, 2026

May 15, 2026

Valion Bio (VBIO) Reports Financial Position and Strategic Focus for 2026 - GuruFocus

May 15, 2026

May 14, 2026

Valion Bio's Velocity Bioworks Secures Exclusive Commercial Lice - GuruFocus

May 14, 2026

May 14, 2026

VBIO Technical Analysis & Stock Price Forecast - Intellectia AI

May 14, 2026

May 14, 2026

VBIO PE Ratio & Valuation, Is VBIO Overvalued - Intellectia AI

May 14, 2026

May 14, 2026

VBIO Should I Buy - Intellectia AI

May 14, 2026

May 14, 2026

VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - GuruFocus

May 14, 2026

May 14, 2026

Valion Bio Reports Q1 2026 Earnings and Strategic Outlook - Intellectia AI

May 14, 2026

May 14, 2026

Valion Bio Reports Q1 Results, Advances Entolimod Platform - TipRanks

May 14, 2026

May 14, 2026

Valion Bio, Inc. Common Stock Q1 2026 Earnings Call Transcript - MarketBeat

May 14, 2026

May 14, 2026

Valion Bio, Inc. 1Q 2026: Revenue $24K, Net loss $(6.20M), EPS $(2.23) — 10-Q Summary - TradingView

May 14, 2026

May 14, 2026

Valion Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

[10-Q] Valion Bio, Inc. Quarterly Earnings Report - Stock Titan

May 14, 2026

May 14, 2026

VBIO: Velocity Bioworks launch and federally funded entolimod development drive 2026 growth outlook - TradingView

May 14, 2026

May 14, 2026

Valion Bio subsidiary secures exclusive NMR platform license - Investing.com

May 14, 2026

May 14, 2026

Transcript : Valion Bio, Inc., Q1 2026 Earnings Call, May 14, 2026 - marketscreener.com

May 14, 2026

May 14, 2026

Valion Bio Q1 2026 Earnings Call: Complete Transcript - Benzinga

May 14, 2026

May 14, 2026

Valion Bio reports first quarter 2026 financial results - marketscreener.com

May 14, 2026

May 14, 2026

Valion Bio Reports First Quarter 2026 Financial Results - TradingView

May 14, 2026